Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression

被引:13
|
作者
Dou, Xiao-Lin [1 ]
Xia, Fa-Da [1 ]
Li, Xin-Ying [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Thyroid Surg, Changsha 410000, Hunan, Peoples R China
关键词
Thyroid carcinoma (TC); circ_0003747; MiR-338-3p; PLCD3; CELL-PROLIFERATION; INHIBITS APOPTOSIS; CIRCULAR RNA; CARCINOMA; MIGRATION;
D O I
10.1080/15592294.2023.2210339
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The circular RNAs (circRNAs) involved in competitive endogenous RNA (ceRNA) mechanism are critical modulators affecting pathogenesis of thyroid carcinoma (TC). The study's goal was to investigate the effects of circ 0003747 on the biological progression of papillary thyroid cancer (PTC). Normal thyroid cells Nthy-ori3-1 and TC derived cell lines were used in our study. Sanger sequencing and RNase R treatment were utilized for validating the circular structure of circ_0003747. In our work, circ_0003747 was found to be highly expressed in TC cells. Circ_0003747 knockdown reduced TC cell viability, proliferation, migration, and invasion while increasing cell apoptosis. Circ_0003747 targeted and negatively regulated miR-338-3p expression. Besides, miR-338-3p interacted with PLCD3 to repress its expression. Overexpression of miR-338-3p inhibited TC cell progression, and PLCD3 reversed these effects. Furthermore, PLCD3 overexpression reversed the effects of circ_0003747 knockdown on TC cells. Additionally, the knockdown of circ_0003747 remarkably suppressed tumour size and growth, restrained PLCD3 expression and promoted miR-338-3p expression in nude mice. In conclusion, circ_0003747 facilitated the biological progression of TC by modulating the miR-338-3p/PLCD3 axis, and it may be a new target for TC treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] CircRNA-ABCB10 promotes gastric cancer progression by sponging miR-1915-3p to upregulate RaC1
    Liu, Junhui
    Qiu, Guanglin
    Wang, Haijiang
    Li, Na
    Liao, Xinhua
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (07) : 896 - 904
  • [42] Hsa_circFOXP1 Contributes to Breast Cancer Progression through Regulating miR-338-3p
    Wu, Kaiding
    Cheng, Kunkun
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (05):
  • [43] CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling
    Wu, Dejun
    Li, Yuqin
    Xu, Anjun
    Tang, Wenqing
    Yu, Bo
    CANCERS, 2023, 15 (07)
  • [44] CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p
    Sun, Ranran
    Li, Hua
    Li, Jianhao
    Shen, Shen
    Cui, Guangying
    Dong, Gang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) : 845 - 852
  • [45] RETRACTION: Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p (Retraction of Vol 12, Pg 6577, 2019)
    Zhang, L.
    Ding, F.
    ONCOTARGETS AND THERAPY, 2023, 16 : 1021 - 1022
  • [46] circCUX1 promotes neuroblastoma progression and glycolysis by regulating the miR-338-3p/PHF20 axis
    Wang, Yan
    Niu, Qin
    Dai, Jie
    Shi, Haitang
    Zhang, Jinzhi
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2021, 40 (01) : 17 - 29
  • [47] Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression
    Nie, Chunlei
    Han, Jihua
    Bi, Wen
    Qiu, Zhilin
    Chen, Lili
    Yu, Jiawei
    Pang, Rui
    Liu, Bo
    Sheng, Ruinan
    Zhang, Jiewu
    CELL CYCLE, 2022, 21 (02) : 126 - 139
  • [48] LINC00689 induces gastric cancer progression via modulating the miR-338-3p/HOXA3 axis
    Lu, Hui
    Zhang, Qian
    Sun, Yaqiong
    Wu, Dedong
    Liu, Liying
    JOURNAL OF GENE MEDICINE, 2020, 22 (12):
  • [49] Circ_0044520 regulates the progression of laryngeal squamous cell carcinoma via the miR-338-3p/ROR2 axis
    Yang, Huijun
    Yu, Gang
    Wang, Yan
    Guo, Xing
    HISTOLOGY AND HISTOPATHOLOGY, 2022, 37 (06) : 513 - 526
  • [50] Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc
    Wei, Liping
    Jiang, Zhaoyan
    Chen, Shujuan
    Xia, Ning
    Kong, Jiejun
    Chang, Yan
    Hou, Zhibo
    ANTICANCER RESEARCH, 2024, 44 (12) : 5405 - 5423